Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -4.52% is 87% below its 5-year average of -2.42%, near the high end of its 5-year range (-48.86%–5.68%).
6.71% below its 12-month average of -4.24%.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-07-31): 5.68%.
NET PROFIT MARGIN
-4.52%
NET PROFIT MARGIN AVG TTM
-4.24%
NET PROFIT MARGIN AVG 3Y
-0.85%
NET PROFIT MARGIN AVG 5Y
-2.42%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-6.71%
CURRENT VS 3Y AVG
-429.05%
CURRENT VS 5Y AVG
-86.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-1638.46%
vs the sector median at left
High Tide Inc.
Market Cap
$238.57M
Net Profit Margin
-4.52%
TTM Avg
-4.24%
3Y Avg
-0.85%
5Y Avg
-2.42%
Market Cap
$238.38M
Net Profit Margin
-6138.26%
TTM Avg
-3731.55%
3Y Avg
-4082.97%
5Y Avg
-2721.98%
Market Cap
$237.81M
Net Profit Margin
-13.54%
TTM Avg
-22.79%
3Y Avg
-26.12%
5Y Avg
-61.39%
Market Cap
$236.07M
Net Profit Margin
-183.90%
TTM Avg
-383.83%
3Y Avg
-191.92%
5Y Avg
-127.94%
Market Cap
$241.39M
Net Profit Margin
62.87%
TTM Avg
27.75%
3Y Avg
54.97%
5Y Avg
-757.17%
Market Cap
$235.24M
Net Profit Margin
29.04%
TTM Avg
31.61%
3Y Avg
31.96%
5Y Avg
30.60%
Market Cap
$241.95M
Net Profit Margin
N/A
TTM Avg
-26.91%
3Y Avg
-35.21%
5Y Avg
-46.29%
Market Cap
$234.90M
Net Profit Margin
-5.14%
TTM Avg
33.66%
3Y Avg
36.64%
5Y Avg
40.60%
Market Cap
$234.70M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| High Tide Inc. (HITI) | $238.57M | -4.52% | -4.24% | -0.85% | -2.42% |
| Quantum-Si incorporated (QSI)vs › | $238.38M | -6138.26% | -3731.55% | -4082.97% | -2721.98% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.81M | -13.54% | -22.79% | -26.12% | -61.39% |
| Invivyd, Inc. (IVVD)vs › | $236.07M | -183.90% | -383.83% | -191.92% | -127.94% |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 62.87% | 27.75% | 54.97% | -757.17% |
| Utah Medical Products, Inc. (UTMD)vs › | $235.24M | 29.04% | 31.61% | 31.96% | 30.60% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.95M | N/A | -26.91% | -35.21% | -46.29% |
| SIGA Technologies, Inc. (SIGA)vs › | $234.90M | -5.14% | 33.66% | 36.64% | 40.60% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $234.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $243.21M | -910.14% | -61.65% | -565.10% | -430.67% |
Operating Margin
0.6%
Net Profit Margin
-4.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-07-31 | 5.68% |
| 2026-04-30 | -0.11% |
| 2026-01-31 | 0.68% |
| 2025-10-31 | -27.82% |
| 2025-07-31 | 0.40% |
| 2025-04-30 | -2.10% |
| 2025-01-31 | -1.97% |
| 2024-10-31 | -3.39% |
| 2024-07-31 | 0.54% |
| 2024-04-30 | -0.02% |
| 2024-01-31 | -0.27% |
| 2023-12-29 | -24.22% |
| 2023-07-31 | -2.30% |
| 2023-04-30 | -1.31% |
| 2023-01-31 | -3.34% |
| 2022-10-31 | -48.86% |
| 2022-07-31 | -2.44% |
| 2022-04-30 | -10.25% |
| 2022-01-31 | -10.84% |
| 2021-10-31 | -9.06% |
| 2021-07-31 | -3.50% |
| 2021-04-30 | -30.18% |
| 2021-01-31 | -44.02% |
| 2020-10-31 | -6.46% |
| 2020-07-31 | 15.68% |
| 2020-04-30 | -23.61% |
| 2020-01-31 | -28.79% |
| 2019-10-31 | -134.67% |
| 2019-07-31 | -44.59% |
| 2019-04-30 | -49.82% |
| 2019-01-31 | -75.58% |
| 2018-10-31 | -183.79% |
| 2018-07-31 | -27.82% |
| 2018-04-30 | -25.48% |
| 2018-01-31 | 11.89% |
| 2017-10-31 | -10.30% |
| 2017-07-31 | 19.54% |
